全文获取类型
收费全文 | 7975篇 |
免费 | 416篇 |
国内免费 | 61篇 |
专业分类
耳鼻咽喉 | 65篇 |
儿科学 | 225篇 |
妇产科学 | 192篇 |
基础医学 | 1118篇 |
口腔科学 | 196篇 |
临床医学 | 637篇 |
内科学 | 1844篇 |
皮肤病学 | 177篇 |
神经病学 | 929篇 |
特种医学 | 406篇 |
外科学 | 888篇 |
综合类 | 36篇 |
预防医学 | 385篇 |
眼科学 | 172篇 |
药学 | 526篇 |
中国医学 | 38篇 |
肿瘤学 | 618篇 |
出版年
2024年 | 13篇 |
2023年 | 83篇 |
2022年 | 149篇 |
2021年 | 235篇 |
2020年 | 135篇 |
2019年 | 187篇 |
2018年 | 244篇 |
2017年 | 179篇 |
2016年 | 194篇 |
2015年 | 234篇 |
2014年 | 282篇 |
2013年 | 350篇 |
2012年 | 558篇 |
2011年 | 580篇 |
2010年 | 351篇 |
2009年 | 326篇 |
2008年 | 509篇 |
2007年 | 533篇 |
2006年 | 543篇 |
2005年 | 483篇 |
2004年 | 490篇 |
2003年 | 471篇 |
2002年 | 403篇 |
2001年 | 88篇 |
2000年 | 69篇 |
1999年 | 91篇 |
1998年 | 86篇 |
1997年 | 71篇 |
1996年 | 54篇 |
1995年 | 44篇 |
1994年 | 28篇 |
1993年 | 36篇 |
1992年 | 28篇 |
1991年 | 27篇 |
1990年 | 23篇 |
1989年 | 33篇 |
1988年 | 32篇 |
1987年 | 24篇 |
1986年 | 19篇 |
1985年 | 11篇 |
1984年 | 16篇 |
1983年 | 16篇 |
1982年 | 16篇 |
1981年 | 9篇 |
1979年 | 14篇 |
1978年 | 7篇 |
1977年 | 9篇 |
1974年 | 7篇 |
1970年 | 10篇 |
1967年 | 7篇 |
排序方式: 共有8452条查询结果,搜索用时 15 毫秒
31.
Rachel Wuerstlein Nadia Harbeck Eva-Maria Grischke Dirk Forstmeyer Raquel von Schumann Petra Krabisch Kerstin Lüdtke-Heckenkamp Andrea Stefek Oliver Stoetzer Andrea Grafe Gabriele Kaltenecker Helmut Forstbauer Doris Augustin Iris Schrader Joke Tio Ulrike Nitz Oleg Gluz Ronald E. Kates Monika Karla Graeser 《Breast care (Basel, Switzerland)》2021,16(1):50
BackgroundProtroca evaluated the efficacy and safety of primary and secondary prophylaxis of neutropenia with lipegfilgrastim (Lonquex®) in breast cancer patients receiving neoadjuvant or adjuvant chemotherapy (CT).Patients and MethodsOf the 255 patients enrolled, 248 patients were evaluable for the intent-to-treat (ITT) and 194 patients for the per-protocol set. Primary and secondary end points after lipegfilgrastim treatment were assessed.ResultsNine patients of the ITT set receiving lipegfilgrastim as primary prophylaxis (n = 222) had febrile neutropenia of grade 3–4 (5 patients) or infection of grade 3–4 (4 patients); 1/26 of those receiving secondary prophylaxis had an event. Dose reductions were performed in 9.5% of the patients. Postponement of cancer CT cycles for >3 days occurred in <15% of patients; 10.8% (92/851 AEs) and 8% (2/25 SAEs) of documented adverse events and serious adverse events, respectively, were related to lipegfilgrastim.ConclusionsApplication of lipegfilgrastim was effective as primary and secondary prophylaxis in the prevention of CT-induced neutropenia in breast cancer. 相似文献
32.
ACE inhibition reduces activity of the plasminogen/plasmin and MMP systems in the brain of spontaneous hypertensive stroke-prone rats 总被引:2,自引:0,他引:2
Liebetrau M Burggraf D Wunderlich N Jäger G Linz W Hamann GF 《Neuroscience letters》2005,376(3):205-209
The spontaneously hypertensive stroke-prone rat (SHR-SP) is an experimental model of malignant hypertension which lead to secondary alterations of the extracellular matrix. Our aim was to determine ACE-inhibitor related changes of proteases involved in the reconstruction of the extracellular matrix in the brain. Twelve SHR-SP rats were randomized into two groups. Each group was treated with either an antihypertensive dose of ramipril or placebo for 6 months. Brain tissue plasminogen activator (t-PA) and urokinase (u-PA) were quantified by using casein-dependent plasminogen zymography, matrix metalloproteinase (MMP)-2 and MMP-9, by MMP-zymography, and tissue inhibitor of MMP (TIMP)-1 and -2, by reverse zymography. The amounts of u-PA, t-PA, and MMPs were significantly reduced in animals treated with ACE inhibitor. Plasminogen zymography showed a 39% reduction of u-PA in the basal ganglia (p < 0.0001); t-PA expression was reduced by 26% in the cortex and by 33% in the basal ganglia (p < 0.0001). MMP-2 expression was reduced by 15% in the cortex (p < 0.05) and by 10% in the basal ganglia (p < 0.05); MMP-9 expression significantly decreased by 37% in the cortex and by 25% in the basal ganglia (p < 0.0001 each). No differences were observed in the amount of TIMP-1 or TIMP-2. These findings provide new insights into the biochemical mechanisms underlying extracellular matrix proliferation and its modulation by ACE inhibitors. Therapeutic alterations that influence the proteolytic systems might prove important in the prevention of extracellular matrix accumulation and secondary microvascular vessel wall changes. 相似文献
33.
Andreas Schalhorn Michael Kühl Gabriele Stupp-Poutot Volkmar Nüssler 《Cancer chemotherapy and pharmacology》1990,25(6):440-444
Summary After the use of d,1-folinic acid (d,1-CHO-THF), pharmacokinetic measurements should take into account 1-CHO-THF and its metabolite 1-methyltetrahydrofolic acid (1-CH3-THF) as well as d-CHO-THF. For this purpose, we developed a simple and rapid assay by combining reversed-phase HPLC to determine total levels of d,1-CHO-THF and CH3-THF and chiral HPLC to separate the biologically active 1-CHO-THF from the inactive d-CHO-THF. We investigated the pharmacokinetics after short-term infusion of 300 mg d,1-CHO-THF in ten healthy volunteers. With a mean of 56.5 min, 1-CHO-THF exhibits a rapid body clearance of 222 ml/min, about 60% of which is caused by metabolism to CH3-THF and 40%, by renal excretion. CH3-THF has a terminal half-life of 208 min and a total body clearance of 88.9 ml/min, which is essentially the same as the renal clearance. Due to the lower clearance of CH3-THF, its AUC (2,132 M × min) exceeds that of 1-CHO-THF (1445 M × min) by approximately 50%. In contrast to that of the reduced 1-folates, the total body and renal clearance of d-CHO-THF is very low, with values of 13.2 and 12.9 ml/min, respectively. This results in a very high AUC of 24, 269 M × min, which is higher by factors of 17 and 11 than those of 1-CHO-THF and CH3-THF, respectively. The implications of the distinct kinetics of the reduced 1-folates and d-CHO-THF for the efficacy of folinic acid/5-fluorouracil therapy and adequate protocols for the treatment of advanced colorectal cancer are discussed.Abbreviations CH2-THF
N-5,N-10-methylenetetnahydrofolic acid
- CH3-THF
N-5-methyltetrahydrofolic acid
- CHO-THF
N-5-formyltetrahydrofolic acid
- 5-FU
5-fluorouracil
- FBAL
-fluoro--alanine
- FUH2
dihydrofluorouracil
- FUPA
-fluoroureidopropionic acid
Dedicated to Prof. Dr. W. Wilmanns on the occasion of his 60th birthdayThis study was carried out with the support of the Lederle Company, Wolfratshausen 相似文献
34.
Letizia Mazzini Daniela Testa Carla Balzarini Gabriele Mora 《Journal of neurology》1994,241(4):223-227
Based on the hypothesis that free radicals play a general role in the neurodegenerative process in motor neuron disease, we tested selegiline in a group of patients affected by amyotrophic lateral sclerosis (ALS) to examine whether it might modify the progression of the disease. Patients were admitted if they were 25–80 years old and had a confirmed diagnosis of ALS with symptoms lasting no longer than 24 months. Patients with familial ALS, pure progressive bulbar palsy, primary lateral sclerosis or progressive muscle atrophy were excluded; a total of 111 patients were recruited. Fifty-three patients were randomly assigned to receive the drug (selegiline 10 mg/day orally for 6 months) and the remaining 58 were considered ALS controls. Mortality was similar in the two groups (4 and 5 patients respectively), though the difference was not statistically significant. Among the survivors, mean MRC and Norris disability scores and forced vital capacity were fairly similar in the two groups at all times and no statistically significant difference between treated and untreated patients was found. The results did not change when the data were related to age, duration and characteristics of onset of the disease. The rate of progression was significantly more rapid in patients with bulbar symptoms in both groups. Our data do not show any significant effect of selegiline in modifying the progression of ALS. 相似文献
35.
Borghese M Gabriele R Antoniozzi A Teneriello F Caporale A Giuliani A Lombardo F Rengo M 《Il Giornale di chirurgia》1999,20(1-2):35-40
The Authors, after a short introduction concerning the primary carcinoma of the cystic duct and the exact definition according to Farrar's criteria, report a case occurred to their observation, the 35th case of international literature. In particular the importance of some hemato-clinical parameters and instrumental investigation (ERCP, angio-CT) to underlined in order to surgical indication. In the case here reported cholecystectomy uses informed with partial resection of the hepato-choledochus and excision of some periductal and pericholedochus lymph nodes. Finally, the Authors discuss about clinical data and diagnostic and therapeutic trends, on the case of their experience and literature review. 相似文献
36.
Polyamine metabolism in gliomas 总被引:2,自引:0,他引:2
Ralf-Ingo Ernestus Gabriele Röhn Roland Schröder Thomas Els Jin-Yul Lee Norfrid Klug Wulf Paschen 《Journal of neuro-oncology》1996,29(2):167-174
Summary Biosynthesis of the polyamines putrescine, spermidine, and spermine has been found to be activated in tissues with cellular proliferation. In the present study we have investigated polyamine levels and the activity of the first rate-limiting enzyme ornithine decarboxylase (ODC) in tumour samples obtained during operation of 202 patients with gliomas. Biochemical data were closely related to the grading of malignancy and to the morphological characteristics of each sample. Mean ODC activity was significantly higher in all gliomas as compared to peritumoural non-neoplastic brain. Furthermore, it was significantly higher (p 0.001) in anaplastic gliomas who grade III and IV (9.0 ± 9.6 nmol/g/h) than in gliomas WHO grade I and II (3.3 ± 4.2 nmol/g/h). Highest enzyme activity (58.5 nmol/g/h) was found in solid and vital parts of malignant tumours, whereas predominantly necrotic areas exhibited low ODC activity (< 1 nmol/g/h). Thus, intra- and interindividual variability of ODC activity corresponded well to histomorphological heterogeneity in high-grade gliomas. Putrescine levels also increased with rising grade of malignancy, whereas spermidine and spermine levels did not correlate with the histological grading. In conclusion, high ODC activity represents a biochemical marker of malignancy in gliomas, but low values do not prove benignity. The present study reinforces the need of further and more extensive tumour sampling closely related to follow-up investigations in the heterogeneous group of gliomas. 相似文献
37.
AIMS AND BACKGROUND: Isolated vaginal recurrences of endometrial carcinoma are rare, and prognostic factors that predict treatment outcome are still not well defined. The aim of the present study was to evaluate the results of brachytherapy in isolated vaginal recurrences from endometrial carcinoma. METHODS: Thirty-five patients with isolated vaginal recurrences were treated with brachytherapy with intravaginal ovoids or cylinders that were calculated to deliver 6000 to 7000 cGy at the surface. Patients were assessed for size and location of recurrence at presentation, response and complications from therapy. RESULTS: Treatment was well tolerated by most patients. Grade 2 toxicity occurred in 4 patients (3 cases of partial vaginal stenosis and one proctitis). Complete response to radiation was observed in all patients, and an overall 9 failures were observed (4 local, 4 distant and 1 local plus distant). Twenty patients (57%) were alive without evidence of disease at 3 to 11 years following treatment. Site of vaginal recurrence (upper third versus others) and long (more than 12 months versus less than 12 months) interval from hysterectomy were the only factors significantly related to local failures. CONCLUSIONS: Isolated vaginal recurrences following hysterectomy for endometrial carcinoma can be treated with brachytherapy with a low rate of severe toxicity. 相似文献
38.
Identification of an aflatoxin G1-serum albumin adduct and its relevance to the measurement of human exposure to aflatoxins 总被引:1,自引:0,他引:1
A major aflatoxin G1 (AFG1)-albumin adduct has been identifiedand characterized in rats following exposure to AFG1. The productisolated from a Pronase digest of in vivomodified albumin wasidentical by chromatographic retention time to the syntheticproduct obtained by the acylase-catalysed deacetylation productof N-acetyl-L-lysine with 8,9-dihydro- 8,9-dibromo-AFG1. Thein vitro product, AFG1-lysine, was characterized by UV, fluorescence,1H- and 13C-NMR spectroscopy and fast atom bombardment MS. Acompetitive enzyme-linked immunoassay for this adduct was establishedusing polyclonal antibodies to AFB, and this was used togetherwith an HPLC-fluorescence technique to quantitate the in vivoformation of AFG1albumin adducts in comparison to AFB1.A linear doseresponse relationship was observed in ratsfollowing single exposures to 0.1 3 mg AFG1/kg body wt.The levels of AFG1-albumin adducts were determined to be 5.7-and 2.8-fold lower than with equivalent doses of AFB1 as determinedby immunoassay and HPLC fluorescence respectively. The lowerbinding of AFG1 and the lower levels in the human food supplycompared to AFB, suggest that the newly identified adduct couldbe added as an internal standard for methods using the measurementof aflatoxin-albumin adducts to quantitate human exposure toaflatoxin. 相似文献
39.
Septo-optic dysplasia and growth hormone deficiency: accelerated pubertal maturation during GH therapy 总被引:1,自引:0,他引:1
Susanna Freude H Frisch Daniela Wimberger Edith Schober Gabriele Häusler F Waldhauser F Aichner 《Acta paediatrica (Oslo, Norway : 1992)》1992,81(8):641-645
We report four patients (three male, one female) with septo-optic dysplasia and growth hormone deficiency. All had GH therapy for a period of four to eight years until reaching final height. In all four cases bone maturation during puberty was accelerated (1.4 to 1.9 "years"/year), resulting in a final height which was clearly below the predicted height. The progress of pubertal stages was very short in all patients. In three patients TSH and prolactin release after TRH stimulation were increased. These data support a hypothalamic original of the endocrine disorder. Insufficient GH release, even after repeated GHRH stimulation, is in contrast to this assumption. In one case there was a late manifestation of neurohormonal diabetes insipidus, which indicates the possibility of later disease progression. MR imaging of the brain demonstrated variable malformation of the septum pellucidum, chiasma and nervus opticus or the pituitary gland, respectively. 相似文献
40.